Since April, the Trump administration has funnelled $48 million into a programme with the Mayo Clinic, allowing more than 53,000 COVID-19 patients to get plasma infusions. One of those clinical trials, at Columbia University, sputtered to a halt after the outbreak subsided in New York. The policy would ease the clerical burden on hospitals to get clearance for transfusions, further hampering clinical trials, researchers said. An Opening for TrumpThe Trump administration has framed convalescent plasma as a rare bright spot in the pandemic. Birx said she wanted clinical trials to include vulnerable people in nursing homes, the official added.

Source: bd News24 August 05, 2020 09:11 UTC